Articles tagged with Liver Damage
Researchers have made a breakthrough in developing better tests for liver toxicity, which could lead to safer medicines and more drugs reaching patients. The new tests can detect liver damage without causing permanent harm, allowing patients to continue taking medications.
A new study published in Gastroenterology reveals a significant increase in drug-induced liver injury cases worldwide. The most common culprits were antibiotics like amoxicillin-clavulante, immunosuppressants such as azathioprine and biologics like infliximab.
A study published in the American Journal of Clinical Nutrition found that dietary fructose rapidly caused liver damage in an animal model, with damage more than doubling over six weeks. The researchers found that high-fructose diets led to increased intestinal bacteria migration and liver damage, even without weight gain.
Researchers have found significant amounts of coumarin in US cinnamon products, particularly cassia cinnamon. Coumarin has been linked to liver damage in sensitive individuals, highlighting concerns over food safety.
A study found that patients taking tumor necrosis factor-alpha (TNF-α) antagonists are at risk of developing acute liver injury, with most cases involving autoimmunity or hepatocellular injury. The condition is typically resolved after discontinuing the drug, but some patients may experience recurrence.
Scientists have identified biomarkers that predict rapid onset of liver damage in hepatitis C patients after a liver transplant. These markers appear soon after the transplant and before clinical evidence of liver damage, offering new hope for personalized monitoring and treatment options.
A study published in CMAJ found that fluoroquinolone antibiotics, particularly moxifloxacin and levofloxacin, are linked to a higher risk of acute liver injury in older adults. The research suggests these drugs should be subject to regulatory warnings due to their potential harm.
Researchers found that despite similar survival rates, trauma patients in the western United States face higher treatment costs than those in the northeastern region. Analysis of national patient records revealed significant regional differences in care costs, with the west spending up to 35% more on liver injury treatments.
A recent study found that Alzheimer's patients who undergo hospitalization are at risk for complications such as delirium, loss of independence, and death. Researchers also highlighted the risks associated with Flavocoxid, a medical food used to treat osteoarthritis, which can cause liver injury in some patients. Additionally, screenin...
A new study explores the progression of diseases leading to liver damage, affecting diverse populations, including young people. The research shows that obesity is putting teens at risk for developing nonalcoholic fatty liver disease, which may lead to lifelong problems and serious consequences.
Researchers have discovered a way to block cell-to-cell communication in the liver, preventing damage caused by toxic drugs like acetaminophen. The approach has potential for improving drug safety and could lead to new treatment options for patients with drug-induced liver injury.
Researchers have found a way to protect the liver from damage caused by certain drugs, which could lead to improved drug safety. By targeting gap junctions in liver cells, they hope to develop new therapies for treating patients with drug-induced liver injury.
Researchers analyzed data from studies on atrial fibrillation, finding that AFib significantly increases the risk for stroke, heart failure, and death. The studies suggest that AFib has a substantial economic impact on the US healthcare system, warranting further investigation to understand its true costs.
Research shows anti-microbial medications are a leading cause of drug-induced liver injury, with women and minorities disproportionately affected. Liver transplantation offers excellent survival rates, but further investigation is needed to understand the impact of alcohol use and diabetes.
A recent study reveals significant variation in coumarin levels among Cassia cinnamon samples, with powder containing up to 63 times more coumarin than Ceylon cinnamon. Researchers highlight the need for further research to identify factors influencing coumarin levels and potentially allow for lower-coumarin harvesting.
The International Serious Adverse Events Consortium (SAEC) will collaborate with Newcastle University to research the genetics of drug-induced liver injury. The collaboration aims to develop larger and more diverse collections of subjects to better understand the genetic effects contributing to these diseases.
Researchers found that 31P MRS can detect changes in liver ATP levels related to liver damage score and pathologic changes. The study showed significant differences in ATP quantification among groups, indicating its potential as a non-invasive method for detecting early acute hepatic radiation injury.
Researchers have discovered genetic markers that predict individuals at risk for serious drug-induced liver injury. The study found that HLA-B*5701 is a major determinant of liver injury induced by flucloxacillin, and variations on chromosome 3 also influence the risk.
A study has found a genetic marker linked to the risk of acetaminophen-induced liver injury in humans. The researchers used a genetically diverse population of mice to identify a gene called CD44, which is significantly associated with elevated serum ALT levels.
New rodent findings show that chronic drinking causes more injury to the liver than acute or binge drinking, with persistent gene-expression changes and deleterious conditioning. This research highlights the importance of daily, excessive drinking in programming the liver to become dependent on alcohol.
Overdoses of acetaminophen lead to two waves of liver cell destruction and immune system activation. Aspirin is found to downregulate pro-inflammatory cytokine production, providing substantial protection from acetaminophen-induced liver damage.
A Yale study suggests simple aspirin can prevent liver damage from common drug side effects, alcohol abuse, and obesity-related diseases. The study found that aspirin reduced mortality caused by an overdose of acetaminophen and blocked inflammation pathways.
A study published in the World Journal of Gastroenterology found that resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion. The results suggest that resveratrol has protective effects against hepatic I/R injury, making it a potential therapeutic drug for liver transplantation.
Scientists at the University of Edinburgh have discovered a link between cyclophilin A levels and liver damage following a paracetamol overdose. They hope to develop a treatment to block this protein's harmful actions, enabling early identification of high-risk patients.
A new study published in Gastroenterology finds that antibiotics are the single largest class of drugs causing liver injury, affecting 73% of cases. Central nervous system agents were also found to be commonly associated with drug-induced liver injury.
Research published in the World Journal of Gastroenterology found that dietary glycine significantly decreased liver injury due to bile duct ligation in rats. Hepatic injury was reduced by a direct effect on hepatocytes, whereas Kupffer cells did not play a major role in cholestatic models.
Prednisolone administration significantly suppressed serum AST and ALT levels, prevented cell membrane bleb formation, and inhibited calpain mu activation. The study's findings suggest that prednisolone's cytoprotective effect is closely associated with the suppression of these inflammatory markers.
Researchers tested two Ayurvedic herbs, Curcuma longa and Tinospora cordifolia, in a clinical trial to evaluate their ability to prevent hepatotoxicity. The results showed that the formulation was safe and effective in preventing liver damage, with only 0.06% incidence of mild hepatotoxicity compared to 14% in the control group.
Researchers found that sea buckthorn leaf extract reduced liver damage in rats, with significant protection observed at higher doses. The study suggests that the leaves' anti-oxidant properties may help ward off liver disease.
A study published in World Journal of Gastroenterology found that daily alcohol intake above 20g increases the risk of liver injury, while drinking for 5 years or more also poses a significant threat. The research highlights the importance of obesity as a contributing factor to liver damage.
Researchers have confirmed that Jianpi Huoxue decoction inhibits targets in LPS-activated Kupffer cell signal pathway, reducing cytokine expression and endotoxin receptor activity. The study provides new evidence for JHD's potential therapeutic benefits for alcoholic liver injury.
Research led by Dr. Yi-Jia Lou suggests that LTC4 synthesis enzymes contribute to liver injury in a rat FHF model, leading to accumulation of cys-LTs. The study's findings imply further investigation into the expression and activity of these enzymes in managing viral hepatitis patients.
Researchers discovered Ginsenoside Rb1 prevents hepatic microcirculatory disturbance and liver injury in mice subjected to intestine ischemia and reperfusion. The compound is a major effective ingredient of Panax notoginseng, a traditional Chinese herb medicine.
Research found that estrogen improves host response after traumatic injury and decreases liver enzymes associated with damage. The study identified the critical cell surface receptor, GPR30, involved in estrogen's protective effects on the liver.
Researchers at UCSD School of Medicine discovered a cellular receptor involved in triggering cell death is also necessary for tissue repair and regeneration after liver injury. p75 neurotrophin receptor promotes the initial activation of hepatic stellate cells to stimulate new hepatic cell proliferation.
Research on mice carrying a mutated human gene for alpha-1-antitrypsin deficiency found that a non-steroidal anti-inflammatory drug significantly increased liver damage. The study suggests that NSAIDs could exacerbate liver injury in people with alpha-1-AT deficiency, highlighting the need to avoid these drugs.
A new study by Saint Louis University researchers shows a cocktail of ribavirin and Infergen is nearly twice as effective in controlling hepatitis C than standard treatments. Fourteen percent of patients taking the treatment were virus-negative after six months.
A study conducted at the University of California, Davis found that contrast-enhanced sonography accurately depicted 91% of liver, spleen, or renal injuries, outperforming non-contrast enhanced sonography.
The conference focused on idiosyncratic DILI, a rare form of liver damage caused by genetic and non-genetic factors. Researchers aim to develop diagnostic tools to identify patients at risk, with studies examining DNA, lymphocytes, and serum samples from patients who have experienced and recovered from idiosyncratic DILI.
Liver injuries continue to plague the nation's drug development system, causing costly problems for pharmaceutical companies. Dr. Navarro proposes that patients speak with their physicians about their medications to detect liver injury early, as certain individuals are more likely to develop problems due to genetic makeup.
A study analyzing reports of suspected drug-induced liver injury found that AST and bilirubin levels are key predictors of death or liver transplant in patients with severe drug-induced liver disease. Patients with hepatocellular liver damage had a higher mortality rate, highlighting the importance of monitoring these biomarkers.
The Drug-Induced Liver Injury Network (DILIN) will investigate patients who have suffered severe liver injury due to medications. The network aims to identify genetic risk factors for such injuries, which are a major cause of sudden liver failure and new drug failures.
A study published in Hepatology found that severe sleep apnea is a risk factor for liver damage, independent of body mass index. Patients with severe sleep apnea had higher levels of insulin resistance and fatty liver disease, suggesting a link between obstructive sleep apnea and the development of nonalcoholic steatohepatitis.
Researchers found grapefruit seed extract accelerates ulcer healing by reducing gastric acid secretion and promoting blood flow at the ulcer site. The study suggests that grapefruit can be a beneficial addition to the diet for those with ulcers.
Researchers found that nitrite therapy reduces cell death and preserves organ function in mouse models of I/R injury. Nitrite may serve as a therapeutic treatment for I/R disease, particularly in preventing organ dysfunction following surgery or transplantation.
Research reveals that IL-6 activates a pathway in liver cells that triggers protection against hepatitis and immune-mediated liver damage. Two proteins, KC and SAA2, play a crucial role in this protective effect.
The study found that EGCG protected fatty livers from cell damage after I/R injury, reducing necrosis and increasing viable tissue. It also reduced liver fat content by approximately 55 percent and increased hepatic energy stores.
Researchers have identified two types of immune cells in the liver that can cause scarring or repair it. Understanding these cells may lead to new treatments for cirrhosis, a major cause of liver failure.
Researchers found elevated caspase levels in HCV patients with normal aminotransferase levels, associated with higher stages of liver fibrosis. The study suggests that measuring caspase-mediated CK-18 cleavage in serum may be a more sensitive method to detect liver fibrosis in chronic HCV infection.
A new set of guidelines aims to standardize reporting of medical guidelines, reducing misunderstandings among clinicians, patients, and reporters. Blood pressure pills have been found to lower hip fracture risk in older adults, but the protective effect disappears after four months without treatment.
A large-scale clinical trial found that patients treated with the two-drug regimen had a much higher rate of major liver injury compared to those taking isoniazid. The study confirms CDC recommendations for frequent monitoring of patients, highlighting the importance of laboratory testing to detect early liver injury.
A study of 118 people with early Lyme disease found most had a red rash with central redness, not the traditional bull's-eye description. The patients' liver function returned to normal after treatment with antibiotics. Meanwhile, a case report describes pioglitazone causing liver damage in a diabetic patient.
Research has identified DDR2 as a key player in the development of hepatic fibrosis, a liver disease characterized by excessive scar tissue buildup. High levels of DDR2 expression have been linked to advanced fibrosis and poor patient outcomes.
A new UK research study found that creatine supplementation reduces brain damage in mice and rats with traumatic brain injury. Brain damage was reduced by 21%, 36% and 50% respectively when creatine was administered before or after the injury.
Researchers transplanted skeletal muscle cells directly into a damaged area of the heart in a Phase I trial to test their potential to repair and strengthen heart contractions. The goal is to improve cardiac function and determine cell survival.
A new study finds that critically injured patients who arrived at trauma centers via private transportation had similar mortality rates, hospital stays, and complications as those transported by emergency medical services (EMS). However, they tended to arrive at the center more quickly following injury, which was associated with better...
Two case reports found that rosiglitazone, a new oral anti-diabetic drug, appeared to be associated with liver damage. In contrast, a large retrospective study on hepatitis C virus showed that infected individuals developed few liver-related illnesses, suggesting they may be at lower risk for progressive liver disease.
Scientists have identified TNF-alpha as a major contributor to early liver injury from long-term alcohol consumption, paving the way for new treatments. The study used gene knockout technology and found that mice lacking TNF receptors fared better on measures of liver injury after alcohol exposure.
A study found that tumor necrosis factor-alpha (TNF-alpha) plays a crucial role in early liver damage caused by alcohol consumption. The researchers used gene knockout technology to show that TNF-alpha mediates the development of liver injury, leading to potential new drug therapies for conditions affecting millions of Americans.
Researchers found an immune molecule that kills damaged cells indirectly by closing receptors to a life-saving protein, shedding new insight on neurodegenerative diseases such as Alzheimer's and stroke. The findings could lead to targeted treatments for brain injuries and diseases involving neurodegeneration.